Visceral Pain - Pipeline Review, H2 2013

Market: Pharmaceuticals and Healthcare

Global, 28 pages report, published by Global Markets Direct

Keywords : Visceral Pain Therapeutic Products under Development, Key Players in Visceral Pain Therapeutics, Visceral Pain Pipeline Overview, Visceral Pain Pipeline, Visceral Pain Pipeline Assessment

Report ThumbnailSeptember-2013
Visceral Pain - Pipeline Review, H2 2013

Summary

Global Markets Direct’s, 'Visceral Pain - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Visceral Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Visceral Pain. Visceral Pain - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Visceral Pain.
- A review of the Visceral Pain products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Visceral Pain pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Visceral Pain.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Visceral Pain pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.
  • List of Figures
  • Number of Products under Development for Visceral Pain, H2 2013 6
  • Products under Development for Visceral Pain - Comparative Analysis, H2 2013 7
  • Products under Development by Companies, H2 2013 8
  • Mid Clinical Stage Products, H2 2013 9
  • Pre-Clinical Stage Products, H2 2013 10
  • Assessment by Monotherapy Products, H2 2013 15
  • Assessment by Route of Administration, H2 2013 16
  • Assessment by Stage and Route of Administration, H2 2013 17
  • Assessment by Molecule Type, H2 2013 18
  • Assessment by Stage and Molecule Type, H2 2013 19
  • List of Tables
  • Number of Products Under Development for Visceral Pain, H2 2013 6
  • Products under Development for Visceral Pain - Comparative Analysis, H2 2013 7
  • Number of Products under Development by Companies, H2 2013 8
  • Comparative Analysis by Mid Clinical Stage Development, H2 2013 9
  • Comparative Analysis by Pre-Clinical Stage Development, H2 2013 10
  • Products under Development by Companies, H2 2013 11
  • Nektar Therapeutics, H2 2013 12
  • Astellas Pharma Inc., H2 2013 13
  • Trevena, Inc., H2 2013 14
  • Assessment by Monotherapy Products, H2 2013 15
  • Assessment by Stage and Route of Administration, H2 2013 17
  • Assessment by Stage and Molecule Type, H2 2013 19
  • Visceral Pain Therapeutics - Drug Profile Updates 24
  • Visceral Pain Therapeutics - Discontinued Products 25
  • Visceral Pain Therapeutics - Dormant Products 26
  • Table of Contents
  • Table of Contents 2
  • List of Tables 3
  • List of Figures 3
  • Introduction 4
  • Global Markets Direct Report Coverage 4
  • Visceral Pain Overview 5
  • Therapeutics Development 6
  • An Overview of Pipeline Products for Visceral Pain 6
  • Visceral Pain Therapeutics under Development by Companies 8
  • Mid Clinical Stage Products 9
  • Comparative Analysis 9
  • Pre-Clinical Stage Products 10
  • Comparative Analysis 10
  • Visceral Pain Therapeutics - Products under Development by Companies 11
  • Companies Involved in Visceral Pain Therapeutics Development 12
  • Nektar Therapeutics 12
  • Astellas Pharma Inc. 13
  • Trevena, Inc. 14
  • Visceral Pain - Therapeutics Assessment 15
  • Assessment by Monotherapy Products 15
  • Assessment by Route of Administration 16
  • Assessment by Molecule Type 18
  • Drug Profiles 20
  • Kappa Opioid Receptor Biased Ligand Program - Drug Profile 20
  • Product Description 20
  • Mechanism of Action 20
  • R&D Progress 20
  • GIC-1001 - Drug Profile 21
  • Product Description 21
  • Mechanism of Action 21
  • R&D Progress 21
  • NKTR-195 - Drug Profile 22
  • Product Description 22
  • Mechanism of Action 22
  • R&D Progress 22
  • ASP-7663 - Drug Profile 23
  • Product Description 23
  • Mechanism of Action 23
  • R&D Progress 23
  • Visceral Pain Therapeutics - Drug Profile Updates 24
  • Visceral Pain Therapeutics - Discontinued Products 25
  • Visceral Pain Therapeutics - Dormant Products 26
  • Appendix 27
  • Methodology 27
  • Coverage 27
  • Secondary Research 27
  • Primary Research 27
  • Expert Panel Validation 27
  • Contact Us 28
  • Disclaimer 28

Please select a license type

Share

Related Products

Global Markets DirectVisceral Pain - Pipeline Review, H2 2013Product ThumbnailVisceral Pain - Pipeline Review, H2 2013, Industry ReportProduct #: 113355
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2017 Global Market Analyst. All Rights Reserved